This week’s View covers articles about the association of low-level alcohol consumption and incident atrial fibrillation in middle-aged adults and the effectiveness of Pfizer-BioNTech and AstraZeneca vaccines against symptomatic disease caused by the severe acute respiratory syndrome coronavirus 2 delta variant and offers key points from an ACC Expert Consensus Decision Pathway on the management of atherosclerotic cardiovascular disease risk reduction in patients with persistent hypertriglyceridemia.